Abstract
Chronic duodenal ulceration is a recurrent disease. Acute exacerbations may be treated effectively with H2-receptor blockers and a variety of other agents. Intermittent treatment may pose risks of recurrence and complication, and these may be greatly reduced by maintenance treatment. Operative management also reduces recurrence rates, which, however, are commoner in patients coming to surgery nowadays. Full-dose maintenance therapy is an effective option for selected patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
